Viewing Study NCT00947895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-01-31 @ 6:13 AM
Study NCT ID: NCT00947895
Status: TERMINATED
Last Update Posted: 2016-03-22
First Post: 2009-07-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone
Sponsor: Neurologique Foundation, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ACTH View
None Acthar gel View
None adrenocorticotropin View
None methylprednisolone View
None solumedrol View
None MS View
None multiple View
None sclerosis View
None relapse View
None exacerbation View
None sub-responsive View
None IV View